Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mélissa Leblanc

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Organic Letters|July 1, 2005
Allocolchicinoid synthesis via direct arylationMélissa Leblanc, Keith Fagnou
Bioorganic & Medicinal Chemistry Letters|June 19, 2013
Peptide backbone replacement of hepatitis C virus NS3 serine protease C-terminal cleavage product analogs: discovery of potent succinamide inhibitorsMurray D Bailey, Josée Bordeleau, Michel Garneau, et al.
Journal of Medicinal Chemistry|March 20, 2013
Discovery of hepatitis C virus NS3-4A protease inhibitors with improved barrier to resistance and favorable liver distributionBenoît Moreau, Jeff A O'Meara, Josée Bordeleau, et al.
Bioorganic & Medicinal Chemistry Letters|June 6, 2013
Synthesis and optimization of a novel series of HCV NS3 protease inhibitors: 4-arylproline analogsFrançois Bilodeau, Murray D Bailey, Punit K Bhardwaj, et al.
ACS Medicinal Chemistry Letters|June 17, 2026
Optimization and <i>In Vivo</i> Characterization of a Series of Cbl‑b Inactive-State InhibitorsMichael J Lambrecht, Jun Liang, Peter Man-Un Ung, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Organic Letters|July 1, 2005
Allocolchicinoid synthesis via direct arylationMélissa Leblanc, Keith Fagnou
Bioorganic & Medicinal Chemistry Letters|June 19, 2013
Peptide backbone replacement of hepatitis C virus NS3 serine protease C-terminal cleavage product analogs: discovery of potent succinamide inhibitorsMurray D Bailey, Josée Bordeleau, Michel Garneau, et al.
Journal of Medicinal Chemistry|March 20, 2013
Discovery of hepatitis C virus NS3-4A protease inhibitors with improved barrier to resistance and favorable liver distributionBenoît Moreau, Jeff A O'Meara, Josée Bordeleau, et al.
Bioorganic & Medicinal Chemistry Letters|June 6, 2013
Synthesis and optimization of a novel series of HCV NS3 protease inhibitors: 4-arylproline analogsFrançois Bilodeau, Murray D Bailey, Punit K Bhardwaj, et al.
ACS Medicinal Chemistry Letters|June 17, 2026
Optimization and <i>In Vivo</i> Characterization of a Series of Cbl‑b Inactive-State InhibitorsMichael J Lambrecht, Jun Liang, Peter Man-Un Ung, et al.
Pageof 1